טוען...
Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme
BACKGROUND: As the most aggressive brain tumor, patients with glioblastoma multiforme (GBM) have a poor prognosis. Our purpose was to explore prognostic value of Polo-like kinase 2 (PLK2) in GBM, a member of the PLKs family. METHODS: The expression profile of PLK2 in GBM was obtained from The Cancer...
שמור ב:
| הוצא לאור ב: | PeerJ |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
PeerJ Inc.
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6873877/ https://ncbi.nlm.nih.gov/pubmed/31763067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.7974 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|